
Darnell A. Pouncil
Examiner (ID: 23, Phone: (571)270-3509 , Office: P/3621 )
| Most Active Art Unit | 3621 |
| Art Unit(s) | 3621, 3688, 3622 |
| Total Applications | 453 |
| Issued Applications | 90 |
| Pending Applications | 53 |
| Abandoned Applications | 316 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 5435534
[patent_doc_number] => 20090170121
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-07-02
[patent_title] => 'ASSAY BUFFER, COMPOSITIONS CONTAINING THE SAME, AND METHODS OF USING THE SAME'
[patent_app_type] => utility
[patent_app_number] => 12/368742
[patent_app_country] => US
[patent_app_date] => 2009-02-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 19599
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0170/20090170121.pdf
[firstpage_image] =>[orig_patent_app_number] => 12368742
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/368742 | Assay buffer, compositions containing the same, and methods of using the same | Feb 9, 2009 | Issued |
Array
(
[id] => 5367185
[patent_doc_number] => 20090304744
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-12-10
[patent_title] => 'METHODS OF ENHANCING IMMUNE RESPONSE IN THE INTRADERMAL COMPARTMENT AND COMPOUNDS USEFUL THEREOF'
[patent_app_type] => utility
[patent_app_number] => 12/368864
[patent_app_country] => US
[patent_app_date] => 2009-02-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 37
[patent_figures_cnt] => 37
[patent_no_of_words] => 39374
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0304/20090304744.pdf
[firstpage_image] =>[orig_patent_app_number] => 12368864
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/368864 | METHODS OF ENHANCING IMMUNE RESPONSE IN THE INTRADERMAL COMPARTMENT AND COMPOUNDS USEFUL THEREOF | Feb 9, 2009 | Abandoned |
Array
(
[id] => 5385285
[patent_doc_number] => 20090226530
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-09-10
[patent_title] => 'POWDERED PROTEIN COMPOSITIONS AND METHODS OF MAKING SAME'
[patent_app_type] => utility
[patent_app_number] => 12/354665
[patent_app_country] => US
[patent_app_date] => 2009-01-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 32149
[patent_no_of_claims] => 49
[patent_no_of_ind_claims] => 38
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0226/20090226530.pdf
[firstpage_image] =>[orig_patent_app_number] => 12354665
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/354665 | Powdered protein compositions and methods of making same | Jan 14, 2009 | Issued |
Array
(
[id] => 5342428
[patent_doc_number] => 20090181078
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-07-16
[patent_title] => 'VACCINE COMPOSITION CONTAINING SYNTHETIC ADJUVANT'
[patent_app_type] => utility
[patent_app_number] => 12/351710
[patent_app_country] => US
[patent_app_date] => 2009-01-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 28
[patent_figures_cnt] => 28
[patent_no_of_words] => 35915
[patent_no_of_claims] => 34
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0181/20090181078.pdf
[firstpage_image] =>[orig_patent_app_number] => 12351710
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/351710 | VACCINE COMPOSITION CONTAINING SYNTHETIC ADJUVANT | Jan 8, 2009 | Abandoned |
Array
(
[id] => 6263357
[patent_doc_number] => 20100297245
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-11-25
[patent_title] => 'METHODS AND COMPOSITIONS FOR ORAL ADMINISTRATION OF PROTEIN AND PEPTIDE THERAPEUTIC AGENTS'
[patent_app_type] => utility
[patent_app_number] => 12/811871
[patent_app_country] => US
[patent_app_date] => 2009-01-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 19
[patent_no_of_words] => 23734
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0297/20100297245.pdf
[firstpage_image] =>[orig_patent_app_number] => 12811871
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/811871 | Methods and compositions for oral administration of protein and peptide therapeutic agents | Jan 7, 2009 | Issued |
Array
(
[id] => 5279507
[patent_doc_number] => 20090131639
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-05-21
[patent_title] => 'ANTIBODY-CONTAINING SOLUTION FORMULATIONS'
[patent_app_type] => utility
[patent_app_number] => 12/349986
[patent_app_country] => US
[patent_app_date] => 2009-01-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8485
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0131/20090131639.pdf
[firstpage_image] =>[orig_patent_app_number] => 12349986
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/349986 | Antibody-containing solution formulations | Jan 6, 2009 | Issued |
Array
(
[id] => 5992550
[patent_doc_number] => 20110014203
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-01-20
[patent_title] => 'FORMULATION'
[patent_app_type] => utility
[patent_app_number] => 12/810906
[patent_app_country] => US
[patent_app_date] => 2008-12-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 8899
[patent_no_of_claims] => 48
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0014/20110014203.pdf
[firstpage_image] =>[orig_patent_app_number] => 12810906
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/810906 | FORMULATION | Dec 21, 2008 | Abandoned |
Array
(
[id] => 6525730
[patent_doc_number] => 20100203511
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-08-12
[patent_title] => 'Retinoid metabolizing protein'
[patent_app_type] => utility
[patent_app_number] => 12/314893
[patent_app_country] => US
[patent_app_date] => 2008-12-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 31
[patent_figures_cnt] => 31
[patent_no_of_words] => 24737
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0203/20100203511.pdf
[firstpage_image] =>[orig_patent_app_number] => 12314893
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/314893 | Retinoid metabolizing protein | Dec 17, 2008 | Abandoned |
Array
(
[id] => 6505832
[patent_doc_number] => 20100260853
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-10-14
[patent_title] => 'COMPOSITIONS FOR PULMONARY DELIVERY'
[patent_app_type] => utility
[patent_app_number] => 12/747203
[patent_app_country] => US
[patent_app_date] => 2008-12-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 22519
[patent_no_of_claims] => 60
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0260/20100260853.pdf
[firstpage_image] =>[orig_patent_app_number] => 12747203
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/747203 | COMPOSITIONS FOR PULMONARY DELIVERY | Dec 10, 2008 | Abandoned |
Array
(
[id] => 5574995
[patent_doc_number] => 20090142356
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-06-04
[patent_title] => 'Pharmaceutical Composition of F(ab\')2 Antibody Fragments and a Process for the Preparation Thereof'
[patent_app_type] => utility
[patent_app_number] => 12/326687
[patent_app_country] => US
[patent_app_date] => 2008-12-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 7483
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0142/20090142356.pdf
[firstpage_image] =>[orig_patent_app_number] => 12326687
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/326687 | Pharmaceutical composition of F(ab′)2 antibody fragments and a process for the preparation thereof | Dec 1, 2008 | Issued |
Array
(
[id] => 10586661
[patent_doc_number] => 09308257
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-04-12
[patent_title] => 'Protein formulation'
[patent_app_type] => utility
[patent_app_number] => 12/744745
[patent_app_country] => US
[patent_app_date] => 2008-11-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 48
[patent_figures_cnt] => 48
[patent_no_of_words] => 106756
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 86
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12744745
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/744745 | Protein formulation | Nov 25, 2008 | Issued |
Array
(
[id] => 7728511
[patent_doc_number] => 08101176
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-01-24
[patent_title] => 'Compositions and methods related to TIM-3, a TH1-specific cell surface molecule'
[patent_app_type] => utility
[patent_app_number] => 12/276977
[patent_app_country] => US
[patent_app_date] => 2008-11-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 22
[patent_no_of_words] => 25020
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 68
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/101/08101176.pdf
[firstpage_image] =>[orig_patent_app_number] => 12276977
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/276977 | Compositions and methods related to TIM-3, a TH1-specific cell surface molecule | Nov 23, 2008 | Issued |
Array
(
[id] => 8555170
[patent_doc_number] => 08329642
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2012-12-11
[patent_title] => 'Formula and method to enhance external physiognomy'
[patent_app_type] => utility
[patent_app_number] => 12/271112
[patent_app_country] => US
[patent_app_date] => 2008-11-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6116
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 135
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12271112
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/271112 | Formula and method to enhance external physiognomy | Nov 13, 2008 | Issued |
Array
(
[id] => 9009562
[patent_doc_number] => 08524860
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-09-03
[patent_title] => 'Peptides with capacity to bind to scurfin and applications'
[patent_app_type] => utility
[patent_app_number] => 12/743616
[patent_app_country] => US
[patent_app_date] => 2008-11-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 14702
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 47
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12743616
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/743616 | Peptides with capacity to bind to scurfin and applications | Nov 13, 2008 | Issued |
Array
(
[id] => 6349225
[patent_doc_number] => 20100249018
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-09-30
[patent_title] => 'COMPOSITION AND METHOD FOR PREVENTING AND TREATING IMMUNE-RELATED DISORDER'
[patent_app_type] => utility
[patent_app_number] => 12/740729
[patent_app_country] => US
[patent_app_date] => 2008-11-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 28
[patent_figures_cnt] => 28
[patent_no_of_words] => 7380
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0249/20100249018.pdf
[firstpage_image] =>[orig_patent_app_number] => 12740729
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/740729 | Composition and method for preventing and treating immune-related disorder | Nov 2, 2008 | Issued |
Array
(
[id] => 5421980
[patent_doc_number] => 20090148435
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-06-11
[patent_title] => 'ANTIBODY PURIFICATION BY CATION EXCHANGE CHROMATOGRAPHY'
[patent_app_type] => utility
[patent_app_number] => 12/260623
[patent_app_country] => US
[patent_app_date] => 2008-10-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 14386
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0148/20090148435.pdf
[firstpage_image] =>[orig_patent_app_number] => 12260623
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/260623 | ANTIBODY PURIFICATION BY CATION EXCHANGE CHROMATOGRAPHY | Oct 28, 2008 | Abandoned |
Array
(
[id] => 5515686
[patent_doc_number] => 20090215993
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-08-27
[patent_title] => 'Mycophenolic acid immunogens and antibodies'
[patent_app_type] => utility
[patent_app_number] => 12/257704
[patent_app_country] => US
[patent_app_date] => 2008-10-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 4562
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0215/20090215993.pdf
[firstpage_image] =>[orig_patent_app_number] => 12257704
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/257704 | Mycophenolic acid immunogens and antibodies | Oct 23, 2008 | Abandoned |
Array
(
[id] => 11296744
[patent_doc_number] => 09504737
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-11-29
[patent_title] => 'Immune response inducer'
[patent_app_type] => utility
[patent_app_number] => 12/739723
[patent_app_country] => US
[patent_app_date] => 2008-10-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 8
[patent_no_of_words] => 25682
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 100
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12739723
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/739723 | Immune response inducer | Oct 22, 2008 | Issued |
Array
(
[id] => 5539692
[patent_doc_number] => 20090221497
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-09-03
[patent_title] => 'Immunodynamic complexes and methods for using and preparing such complexes'
[patent_app_type] => utility
[patent_app_number] => 12/289092
[patent_app_country] => US
[patent_app_date] => 2008-10-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 27965
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0221/20090221497.pdf
[firstpage_image] =>[orig_patent_app_number] => 12289092
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/289092 | Immunodynamic complexes and methods for using and preparing such complexes | Oct 19, 2008 | Abandoned |
Array
(
[id] => 7711454
[patent_doc_number] => 08092813
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2012-01-10
[patent_title] => 'Polychlorinated biphenyls and squalene-containing adjuvants'
[patent_app_type] => utility
[patent_app_number] => 12/287891
[patent_app_country] => US
[patent_app_date] => 2008-10-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10622
[patent_no_of_claims] => 43
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/092/08092813.pdf
[firstpage_image] =>[orig_patent_app_number] => 12287891
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/287891 | Polychlorinated biphenyls and squalene-containing adjuvants | Oct 13, 2008 | Issued |